Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Overall, this systematic review demonstrates that there is currently some evidence for the therapeutic effect of B12 in the treatment of post-herpetic neuralgia (level II evidence) and the treatment of painful peripheral neuropathy (level III evidence)
There is therefore an urgent need to identify the subtype-specific molecular mechanisms underlying TNBC progression and resistance to chemotherapy that may represent therapeutic targets
By the end of the first month, most patients report a significant reduction in nausea severity, even if mild symptoms linger occasionally with certain foods
Br J Cancer 105: 11071113
US$ 28.42
US$ 28.55
US$ 26.33
US$ 28.05
US$ 24.48
US$ 24.97
US$ 27.64
